Value Research Rating

3 star

Quality Score fund-quick-summary-circle

0/0

Growth Score fund-quick-summary-circle

0/0

Valuation Score fund-quick-summary-circle

0/0

Momentum Score fund-quick-summary-circle

0/0

Nath Bio-Genes (India) Ltd. Share Price

High:loading Low:loading Return: loading

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 161.41 High: 169.45

52 Week Range

Low: 137.55 High: 264.31

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Market capMarket cap information

    ₹319 Cr

  • P/E RatioP/E Ratio information

    8.04

  • P/B RatioP/B Ratio information

    0.5

  • Industry P/EIndustry P/E information

    21.55

  • Debt to EquityDebt to Equity information

    0.18

  • ROEROE information

    6.7 %

  • ROCEROCE information

    7.26 %

  • Div. YieldDiv. Yield information

    1.19 %

  • Book ValueBook Value information

    338.31

  • EPSEPS information

    20.41

10 Years Aggregate

CFO

₹66.33 Cr

EBITDA

₹429.92 Cr

Net Profit

₹237.09 Cr

Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Nath Bio-Genes
-9.85 13.93 -4.63 -10.37 -11.72 -4.97 1.32
BSE FMCG
-0.62 9.24 2.01 6.99 13.46 13.09 9.49
BSE Small Cap
-12.49 9.35 -8.34 5.55 17.55 35.38 15.06
As on 17-Apr-2025
2024
2023
2022
2021
2020
2019
2018
Nath Bio-Genes
-12.08 28.38 -38.90 -3.03 -25.66 -18.44 -9.56
BSE Small Cap
29.04 47.52 -1.80 62.77 32.11 -6.85 -23.41
BSE FMCG
1.47 27.33 16.62 9.32 10.55 -3.58 10.54

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

Detailed View
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View All
loading...

loading...

loading...

3Y Avg -- 5Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peer

View All
Company
Price (₹) Market Cap (₹ Cr) P/E Ratio ROE
323.80 1,609.12 15.84 14.62
323.05 1,941.90 31.36 17.17
1,506.00 7,748.27 25.49 21.87
6.90 676.36 30.14 8.3

Shareholding Pattern

Detailed Holdings
loading...
BLAHBLAH

News & Analysis

All News

About The Company

Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil...  seeds, including cotton and mustard; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; fruit seeds; and seeds for vegetables comprising chilli, onion, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, sweet pepper, green peas, pumpkin, tinda, cabbage, and French beans. It also provides crop protection supplements under the WINPro GOLii, WINall, and Win Chi Win names; and forage seeds under the NUTRIMAX GOLD and NUTRIMAX names. Nath Bio-Genes (India) Limited was founded in 1979 and is based in Mumbai, India.  Read more

  • Incorporated

    2000

  • Chairman

    Satish Kagliwal

  • Managing Director

    Satish Kagliwal

  • Headquarters

    Chhatrapati Sambhajinagar - (Aurangabad), Maharashtra

  • Website

    www.nathbiogenes.com

Edit peer-selector-edit
loading...
loading...
loading...
loading...

Quarterly Updates

FAQs for Nath Bio-Genes (India) Ltd.

The total asset value of Nath Bio-Genes (India) Ltd stood at ₹ 828 Cr as on 31-Dec-24

The share price of Nath Bio-Genes (India) Ltd is ₹168.19 (NSE) and ₹168.10 (BSE) as of 17-Apr-2025 IST. Nath Bio-Genes (India) Ltd has given a return of -11.72% in the last 3 years.

Nath Bio-Genes (India) Ltd has a market capitalisation of ₹ 319 Cr as on 17-Apr-2025. As per Value Research classification, it is a Small Cap company.

The P/B ratio of Nath Bio-Genes (India) Ltd is 0.50 times as on 17-Apr-2025, a 85% discount to its peers’ median range of 3.27 times.

The P/E ratio of Nath Bio-Genes (India) Ltd is 8.04 times as on 17-Apr-2025, a 63% discount to its peers’ median range of 21.55 times.

Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Nath Bio-Genes (India) Ltd and enter the required number of quantities and click on buy to purchase the shares of Nath Bio-Genes (India) Ltd.

Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; fruit seeds; and seeds for vegetables comprising chilli, onion, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, sweet pepper, green peas, pumpkin, tinda, cabbage, and French beans. It also provides crop protection supplements under the WINPro GOLii, WINall, and Win Chi Win names; and forage seeds under the NUTRIMAX GOLD and NUTRIMAX names. Nath Bio-Genes (India) Limited was founded in 1979 and is based in Mumbai, India.

The prominent promoters of Nath Bio-Genes (India) Ltd. are

Name of promoters Holding percentage

ASHU FARMS LLP

13.68%

AKASH FARMS LLP

12.24%

EMERALD SEEDS PRIVATE LIMITED

3.63%
Click here to see the full list

The chairman of the company is Satish Kagliwal, and the managing director is Satish Kagliwal.

The promoters of Nath Bio-Genes (India) Ltd have pledged 7.47% of the total equity as on Dec-24.

Some of the close peers are:

Company Market Cap(₹ Cr)
7,748
1,942
1,609
676
Nath Bio-Genes (India) Ltd. Ratios
Return on equity(%)
6.21
Operating margin(%)
14.01
Net Margin(%)
10.86
Dividend yield(%)
1.19

Yes, TTM profit after tax of Nath Bio-Genes (India) Ltd was ₹40 Cr.